GZMB and non-small cell lung carcinoma: A recent study reported that non-small cell lung cancer showing a complete pathological response to immunotherapy exhibits a stronger immune infiltrate, characterized by higher levels of IFNG, GZMB, NKG7, and M1 macrophages (31).